title: Invited reply to amikacin ototoxicity in children with cancer: the problem is the administration schedule.
authors: The University of Texas Southwestern Medical Center, Dallas, TX.
authors: Kenneth
authors: K
authors: Chen
authors: Alicia
authors: A
authors: Bach
authors: Angela
authors: A
authors: Shoup
authors: Naomi
authors: N
authors: Winick
mesh_terms: D000583:Amikacin / Q000009:adverse effects*; D000617:Aminoglycosides / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000009:adverse effects*; D005260:Female; D034381:Hearing Loss / Q000139:chemically induced*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000188:drug therapy*; D015837:Vestibular Diseases / Q000139:chemically induced*
chemical_list: D000617:Aminoglycosides; D000970:Antineoplastic Agents; D000583:Amikacin